BTK and Miyoshi myopathy: MM-MSCs also boost MM cell “stemness” by activating BTK signaling [30,31] and transfer mitochondria via tunneling nanotubes (TNTs), enhancing oxidative phosphorylation and chemoresistance [32,33].